Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1

Condition:   Hepatitis C, ChronicIntervention:   Drug: Telaprevir and SofosbuvirSponsors:   University of Florida;   Vertex Pharmaceuticals IncorporatedCompleted - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials